Prof. Farhad Hafezi, CMO of the ELZA Institute and Head of the ESCRS Scientific Committee, discusses the evolution of ECO-CAIRS and global clinical standardization at ESCRS Helsinki 2026.
Prof. Hafezi presents advanced cross-linking to improve vision in keratoconus at DGII 2026.
At Keratoconus 360, Prof. Farhad Hafezi of the ELZA Institute explored the evolution of CXL, from the Dresden protocol to Individualized corneal cross-linking protocols like ELZA-sub400 and PACE.
An review of the TNOA Cornea Masterclass discussion on how emerging corneal cross-linking protocols balance procedural efficiency with the necessity of biomechanical efficacy.
ELZA’s CEO and CMO, Nikki and Farhad Hafezi flew to Hong Kong to attend APAO 2026, including an invited symposium presentation by Prof. Farhad Hafezi on Custom CXL.
Swiss newspapers report on a severe contact lens–related eye infection and how an innovative treatment at ELZA Institute helped save vision.
“The eye, once thought sterile and immunoprivileged, is entangled in systemic crosstalk between microbial tenants and ocular health.”
At Swiss Eye Week 2026 in Thun, Prof Farhad Hafezi contributed to ophthalmology education with lectures on corneal cross-linking and ectasia rehabilitation.
Prof Farhad Hafezi represented the ELZA Institute at Keracon 2025 in Goa, contributing invited lectures on evidence-based advances in corneal cross-linking and ectasia management.
Prof. Farhad Hafezi presented five-year outcomes and future directions of the sub400 protocol for thin cornea CXL at the KCXL Experts’ Meeting 2025 in Milan.
